Cargando…

Higher Therapeutic Cyclosporine Levels Early Post-Transplantation Reduces Risks of Acute Graft-Versus-Host Disease and Improves Survival

We studied whether early cyclosporine A (CsA) trough levels were associated with the risk of acute graft-vs.-host disease (GVHD) in 337 patients after either sibling peripheral blood stem cell or double umbilical cord blood transplantation. All patients, regardless of donor type, started CsA at a do...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rogosheske, John R., Fargen, Ashley D., DeFor, Todd E., Warlick, Erica, Arora, Mukta, Blazar, Bruce R., Weisdorf, Daniel J., Brunstein, Claudio G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947241/ https://www.ncbi.nlm.nih.gov/pubmed/24037024 http://dx.doi.org/10.1038/bmt.2013.139

Ejemplares similares

Validation of Minnesota acute graft-versus-host disease Risk Score
por: MacMillan, Margaret L., et al.
Publicado: (2020)

High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group
por: El Jurdi, Najla, et al.
Publicado: (2021)

Factors Predicting Single-Unit Predominance after Double Umbilical Cord Blood Transplantation
por: Ramirez, Pablo, et al.
Publicado: (2011)

High cutaneous amphiregulin expression predicts fatal acute graft‐versus‐host disease
por: Schultz, Brittney, et al.
Publicado: (2022)

MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes
por: Pourhassan, H, et al.
Publicado: (2016)

Polymorphisms in the Base Excision Repair Pathway and Graft-versus-Host Disease
por: Arora, Mukta, et al.
Publicado: (2010)

Donor and Recipient Plasma Follistatin Levels are Associated with Acute Graft-versus-Host Disease in Blood and Marrow Transplant Clinical Trials Network 0402
por: Turcotte, Lucie M., et al.
Publicado: (2017)

Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics
por: Keklik, Fatma, et al.
Publicado: (2018)

CD56(dim)CD57(+)NKG2C(+) NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT
por: Cichocki, Frank, et al.
Publicado: (2015)

High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation
por: Long-Boyle, Janel R, et al.
Publicado: (2010)

Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
por: Hamadani, Mehdi, et al.
Publicado: (2020)

Prognostic factors for clinical outcomes of patients with central nervous system leukemia
por: Bharucha, Jinai, et al.
Publicado: (2020)

COVID19 seroconversion in an unrelated stem cell donor
por: Maakaron, Joseph E., et al.
Publicado: (2020)

Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease
por: Thangavelu, Govindarajan, et al.
Publicado: (2019)

Early E. casseliflavus gut colonization and outcomes of allogeneic hematopoietic cell transplantation
por: Rashidi, Armin, et al.
Publicado: (2019)

Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges
por: Hefazi, Mehrdad, et al.
Publicado: (2021)

Improved patient and graft survival using cyclosporin A in cadaver renal transplantation
por: Johnson, R W G
Publicado: (1985)

Effect of cyclosporin A on the anti-leukaemia action associated with graft-versus-host disease.
por: Denham, S., et al.
Publicado: (1983)

BEAM Conditioning Is Well Tolerated and Yields Similar Survival in Obese and Non-Obese Patients with Lymphoma: No Requirement for Weight-Based Dose Modifications
por: Fair, Christina, et al.
Publicado: (2017)

Life-Threatening Hypertriglyceridemia in a Patient on Ruxolitinib and Sirolimus for Chronic Graft-versus-Host Disease
por: Watson, Allison P., et al.
Publicado: (2018)

Assessment of Cyclosporine Serum Concentrations on the Incidence of Acute Graft Versus Host Disease Post Hematopoietic Stem Cell Transplantation
por: Zeighami, Sara, et al.
Publicado: (2014)

Low cyclosporine concentrations in children and time to acute graft versus host disease
por: Chung, Eun Kyung, et al.
Publicado: (2020)

ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease
por: Jagasia, Madan, et al.
Publicado: (2021)

Transient regulatory T-cell (Treg) depletion with IL-2 diphtheria toxin fusion protein enhances clearance of acute myeloid leukemia by haploidentical natural killer (NK) cells
por: Bachanova, Veronika, et al.
Publicado: (2013)

Emerging translational strategies and challenges for enhancing regulatory T cell therapy for graft-versus-host disease
por: Hippen, Keli L., et al.
Publicado: (2022)

P1328: SUCCESFUL TREATMENT OF GRAFT FAILURE IN AUTOLOGOUS STEM CELL TRANSPLANTATION WITH CYCLOSPORINE
por: Cubillas, D., et al.
Publicado: (2022)

Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft‐versus‐host disease prophylaxis
por: Hernani, Rafael, et al.
Publicado: (2021)

Improving Outcomes After Allogeneic Hematopoietic Cell Transplantation for Hodgkin Lymphoma in the Brentuximab Vedotin Era
por: Hegerova, Livia, et al.
Publicado: (2017)

Requirements for the induction and adoptive transfer of cyclosporine- induced syngeneic graft-versus-host disease
Publicado: (1989)

Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGVHD
por: He, Fiona, et al.
Publicado: (2016)

Prediction of outcomes after second-line treatment for acute graft-versus-host disease
por: Vo, Phuong, et al.
Publicado: (2022)

Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease
por: Le, Hongnga T., et al.
Publicado: (2020)

Influence of Lactate Dehydrogenase and Cyclosporine A Level on the Incidence of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation
por: Song, Moo-Kon, et al.
Publicado: (2009)

Impact of Cyclosporine Levels on the Development of Acute Graft versus Host Disease after Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation
por: García Cadenas, Irene, et al.
Publicado: (2014)

Cytolytic CD4(+) and CD8(+) Regulatory T-Cells and Implications for Developing Immunotherapies to Combat Graft-Versus-Host Disease
por: Bolivar-Wagers, Sara, et al.
Publicado: (2022)

Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death
por: Logan, Brent R., et al.
Publicado: (2023)

Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis
por: Garming Legert, Karin, et al.
Publicado: (2020)

Use of Cyclosporine in Uterine Transplantation
por: Saso, Srdjan, et al.
Publicado: (2012)

Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia
por: Eapen, Mary, et al.
Publicado: (2020)

Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models
por: Abboud, Ramzi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_885hu67sjcrordfhus1c2nkuck